Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-027342

Director sold 105,000 shares at $15.40 ($1,617,000)

  • Director acquired 105,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hutson Nancy J · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-15 Exercise or conversion : show line 1 in the form +30,000 $2.91 $87,300 95,073 D
2021-10-15 Exercise or conversion : show line 2 in the form +30,000 $5.13 $153,900 125,073 D
2021-10-15 Exercise or conversion : show line 3 in the form +15,000 $1.71 $25,650 140,073 D
2021-10-15 Exercise or conversion : show line 4 in the form +30,000 $3.22 $96,600 170,073 D
2021-10-15 Sale : show line 5 in the form −105,000 $15.40 $1,617,000 65,073 D
Open-market sales · 105,000 sh · avg $15.40 · $1,617,000

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-10-15 Exercise or conversion : show line 6 in the form Automatic Stock Option Grant −30,000 0 D
2021-10-15 Exercise or conversion : show line 7 in the form Automatic Stock Option Grant −30,000 0 D
2021-10-15 Exercise or conversion : show line 8 in the form Automatic Stock Option Grant −15,000 0 D
2021-10-15 Exercise or conversion : show line 9 in the form Automatic Stock Option Grant −30,000 0 D
Loading xslF345X03/form4.xml…